Previous research has indicated that miR-16-5p directly targets LDH-A by binding to complementary regions in its 3′-UTR, resulting in the degradation and consequent reduction of lactate accumulation in non-small cell lung cancer (NSCLC) [72]. Here, LDHA is linked to non-small cell lung carcinoma.